Disease/Infection News

RSS

Study questions suitability of anti-retroviral drugs for the young

According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.

25 Apr 2011

Africa's football leaders earn UAM recognition for combating malaria

Today on World Malaria Day, the United Against Malaria campaign, under the Roll Back Malaria Partnership, recognized leaders from Africa's football and corporate spheres for their role in bringing malaria control messages to more than two billion 2010 World Cup spectators through public service announcements and media, and to 10 million employees through "Malaria Safe" corporate initiatives.

25 Apr 2011

Avian flu remains endemic in six countries, could take at least a decade to eradicate, FAO says

It will take at least 10 years to eradicate the H5N1 virus from poultry in the six countries where it is endemic, the U.N. Food and Agriculture Organization said in a report released on Thursday, Agence France-Presse reports.

25 Apr 2011

Global health experts discuss legislative landscape of 112th Congress at Kaiser Family Foundation panel

U.S. global health programs did relatively well in terms of funding in the FY11 budget, but global health policy experts participating in a panel discussion on Wednesday at the Kaiser Family Foundation acknowledged that challenges remain as Congress begins debate on the FY12 budget.

25 Apr 2011

Ahead of Immunization Week, WHO calls for countries to come together to control measles outbreak in Europe

WHO is urging countries in Europe to join together to help control the measles outbreak that has grown to more than 6,500 cases in 33 countries and the potential for worsening outbreaks "in the days ahead as people travel during the Easter holidays," U.N. News Centre reports.

25 Apr 2011

Canadians join hands in fight against meningitis on April 24th

Canadians can join hands in a virtual community with the Meningitis Research Foundation of Canada and become a member of the global family by visiting www.comoonline.org and "joining hands" in the fight against meningitis, and to show support for meningitis awareness and prevention.

25 Apr 2011

Planned Parenthood offers free STI tests during Take Action Tour concert

To help reduce the alarming rate of sexually transmitted infections among young people, Planned Parenthood Southeastern Pennsylvania will give away vouchers for free or low-cost HIV, chlamydia and gonorrhea testing during Hopeless Records' Take Action Tour concert at the Electric Factory in Philadelphia on Saturday, April 23rd, 5:30-8:30 p.m.

25 Apr 2011

U.N. Secretary-General calls for scale up of global malaria efforts ahead of World Malaria Day

Global malaria control efforts must be significantly scaled up if the world is to reach the goal of reducing malaria deaths to almost zero by 2015, U.N. Secretary-General Ban Ki-moon said in a message on Thursday ahead of World Malaria Day, which is officially observed on Monday, the U.N. News Centre writes.

25 Apr 2011

Group B streptococci continues to increase risk of sepsis in newborns

Bloodstream infections in newborns can lead to serious complications with substantial morbidity and mortality. What's more, the pathogens responsible for neonatal infections have changed over time. In recent years, however, antibiotic prophylaxis given to at-risk mothers has reduced the incidence of early-onset group B streptococcal infections among their babies.

25 Apr 2011

FDA approves Sanofi Pasteur's meningococcal vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration has granted licensure to expand the indication for its meningococcal conjugate vaccine, Menactra, to include a two-dose schedule for infants and children 9 months through 23 months of age.

25 Apr 2011

AHF opposes Florida officials' AIDS budget proposal at 'Rule 64D' hearings

Beginning Monday April 25th the Florida Department of Health is conducting four public hearings on proposed reductions to the eligibility threshold to Florida's AIDS Drug Assistance Program, AIDS Insurance Continuation Program, Housing Opportunities for Persons with AIDS, and possibly other Ryan White funded programs and services.

25 Apr 2011

AP reports on Global Fund malaria drug thefts, issues correction

The Associated Press on Wednesday published an article reporting that hundreds of millions of dollars of malaria medication had been stolen from the Global Fund to Fight AIDS, Tuberculosis and Malaria, but later issued a correction.

25 Apr 2011

Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment

Sequella, a clinical-stage pharmaceutical company focused on commercializing novel antibiotics to treat life-threatening infectious diseases, and Maxwell Biotech Venture Fund announced their agreement to complete the clinical development and commercialize SQ109 for treatment of tuberculosis in the Russian Federation and neighboring Commonwealth of Independent States countries, including Armenia, Azerbaijan, Belorussia, Kazakhstan, Kyrgyzstan, Moldova, Tajikistan, Turkmenistan, and Ukraine.

25 Apr 2011

Creative approach can tackle bacterial infections in patients with cystic fibrosis

An over-the-counter drug used to treat diarrhea combined with minocycline, an antibiotic used to treat bacterial infections, could one day change the lives of those living with cystic fibrosis.

25 Apr 2011

Anacor's AN2728 and GSK '052 new data to be presented at upcoming meetings

Anacor Pharmaceuticals announced today that it will present data on two of its compounds at the following conferences: “Safety and efficacy of AN2728 ointment in a phase 2b dose-ranging bilateral study of mild-to-moderate plaque psoriasis”.

25 Apr 2011

Recent releases in Global Health

When health ministers gather for the World Health Assembly in May they will try to come up with a solution to "a dilemma that has dogged decision-makers for decades - whether and when to destroy the last remaining stocks of the smallpox virus," David Heymann and Emma Ross, both of the Global Health Security Centre at Chatham House, write in an article in The World Today.

25 Apr 2011

Sanofi Pasteur receives FDA approval for Menactra to prevent meningococcal disease

The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years.

24 Apr 2011

Congressman Holt congratulates Vaxinnate for BARDA award to develop next generation of flu vaccines

U.S. Congressman Rush Holt (R-12th) visited the headquarters of VaxInnate Corporation today, where he congratulated the biotechnology company on having received a U.S. government contract to fund development of the next generation of flu vaccines and called for more technology investments to improve the health of all Americans.

22 Apr 2011

Idera announces delay in commencement of IMO-2125 Phase 2 clinical trial in treatment-naive HCV patients

Idera Pharmaceuticals, Inc. today announced that it has chosen to delay initiating its planned Phase 2 clinical trial of IMO-2125 based on preliminary data from a 26-week nonclinical toxicology study of IMO-2125 in rodents. The Phase 2 clinical trial involves the evaluation of IMO-2125 plus ribavirin in treatment-naïve, genotype 1 hepatitis C virus (HCV) patients.

22 Apr 2011

UNITAID has raised $2B through airline tax since 2006, could be model for G20 development funding, UNITAID chair says

UNITAID, an international drug financing program established to help fight HIV/AIDS, tuberculosis and malaria in developing countries, has raised about $2 billion since 2006 through taxes on airline tickets in 15 countries, Philippe Douste-Blazy, chair of the UNITAID executive board, told reporters in Washington on Wednesday, Agence France-Presse reports. According to Douste-Blazy, UNITAID's experience could provide a model for G20 development funding efforts.

22 Apr 2011

Disease/Infection News

Study questions suitability of anti-retroviral drugs for the young

Africa's football leaders earn UAM recognition for combating malaria

Avian flu remains endemic in six countries, could take at least a decade to eradicate, FAO says

Global health experts discuss legislative landscape of 112th Congress at Kaiser Family Foundation panel

Ahead of Immunization Week, WHO calls for countries to come together to control measles outbreak in Europe

Canadians join hands in fight against meningitis on April 24th

Planned Parenthood offers free STI tests during Take Action Tour concert

U.N. Secretary-General calls for scale up of global malaria efforts ahead of World Malaria Day

Group B streptococci continues to increase risk of sepsis in newborns

FDA approves Sanofi Pasteur's meningococcal vaccine

AHF opposes Florida officials' AIDS budget proposal at 'Rule 64D' hearings

AP reports on Global Fund malaria drug thefts, issues correction

Maxwell Biotech, Sequella enter license agreement to commercialize SQ109 for TB treatment

Creative approach can tackle bacterial infections in patients with cystic fibrosis

Anacor's AN2728 and GSK '052 new data to be presented at upcoming meetings

Recent releases in Global Health

Sanofi Pasteur receives FDA approval for Menactra to prevent meningococcal disease

Congressman Holt congratulates Vaxinnate for BARDA award to develop next generation of flu vaccines

Idera announces delay in commencement of IMO-2125 Phase 2 clinical trial in treatment-naive HCV patients

UNITAID has raised $2B through airline tax since 2006, could be model for G20 development funding, UNITAID chair says

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News